Literature DB >> 8981680

Some statistical issues in project prioritization in the pharmaceutical industry.

S Senn1.   

Abstract

Various aspects of portfolio management and project prioritization within the pharmaceutical industry are examined. It is shown that the cost and probability architecture of a project is a crucial aspect of its value. An appropriate simple tool for ranking projects is the Pearson index. Various difficulties are considered.

Mesh:

Year:  1996        PMID: 8981680     DOI: 10.1002/(SICI)1097-0258(19961230)15:24<2689::AID-SIM503>3.0.CO;2-K

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  3 in total

1.  Advances in Nuclear Magnetic Resonance for Drug Discovery.

Authors:  Robert Powers
Journal:  Expert Opin Drug Discov       Date:  2009-10-01       Impact factor: 6.098

Review 2.  Role of pharmacoeconomic analysis in R&D decision making: when, where, how?

Authors:  Paul Miller
Journal:  Pharmacoeconomics       Date:  2005       Impact factor: 4.981

3.  Decision-theoretic designs for a series of trials with correlated treatment effects using the Sarmanov multivariate beta-binomial distribution.

Authors:  Siew Wan Hee; Nicholas Parsons; Nigel Stallard
Journal:  Biom J       Date:  2017-07-26       Impact factor: 2.207

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.